Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug4791 | treated with hyperimmune plasma Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D019052 | Depression, Postpartum NIH | 0.33 |
D003863 | Depression, NIH | 0.11 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The aim of this study is to explore the feasibility of delivering clinical mindfulness groups for families affected with postpartum depression and anxiety (PPDA). Families with PPDA are a vulnerable population who already face challenges during the postpartum period, but now the Covid-19 era has brought extra challenges - lower availability of family members or support systems to help in person, older children at home as childcare facilities are closed, etc. Clinical mindfulness groups are now being run online to support this population, with the current barriers of having to stay at home. Through this study, we want to capture the challenges that both clinicians and participants might face using virtual platforms (e.g. technical difficulties), to see whether online delivery of clinical mindfulness groups is feasible.
Description: Assessed via participant attendance and clinician survey about technological difficulties
Measure: Feasibility Time: Weekly (Week 1-8)Description: Self-report questionnaire completed by participants
Measure: Acceptance & Satisfaction Time: Week 8Description: This is a newly developed self-report measure that explores couple interactions and relationship satisfaction
Measure: Relationship & Interactions Time: Week 1, 4, 8, and Follow-upDescription: Demographics questionnaire sent to participants
Measure: Demographics Time: Week 1Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports